Influx Healthtech Ltd (INFLUX) is currently trading at 257.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Influx Healthtech is a Mumbai‑based contract development and manufacturing organization (CDMO) that produces nutraceuticals, cosmetics, ayurveda, pet care, and homecare products across tablets, capsules, softgels, powders, RTD beverages, protein bars and external formulations using four GMP‑certified manufacturing facilities and end‑to‑end regulatory support for domestic and export clients. The company reported FY26 revenue of about INR146 crore, H2 FY26 revenue of INR80.1 crore (41% YoY growth), full year EBITDA around INR29.9 crore with EBITDA margin expansion to 20.3%, and PAT of INR20.5 crore representing a 14% PAT margin and a cash surplus of INR25.2 crore as of March 31, 2026. Management is commissioning a new 75,000 square foot nutraceutical facility (2.5x capacity uplift) by Jul–Aug 2026, expects the new plant to contribute roughly INR40–50 crore in the first partial year, and targets INR450–500 crore revenue by FY29 while maintaining margin discipline and minimal additional debt. Influx Healthtech is scaling product formats and capabilities with a dedicated RTD subsidiary (Olahey Wellness Private Limited), a planned canning and carbonated beverage line, Quick Snap single‑dose format and pet food extrusion capacity expansion to serve growing domestic and international demand, particularly in Africa and the UAE markets.

Over the past 52 weeks, Influx Healthtech Ltd has traded between a low of ₹168.50 and a high of ₹315.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Influx Healthtech Ltd has a market capitalization of approximately 594.97. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Influx Healthtech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.11 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 594.97 Cr, Influx Healthtech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Influx Healthtech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Influx Healthtech Ltd is 31.11. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.